Related Experiment Videos

Development of acute myelocytic leukemia in patients with Crohn's disease

L Halme1, J von Knorring, E Elonen

  • 1Fourth Department of Surgery, Helsinki University Central Hospital, Finland.

Insights

Two Crohn's disease patients developed acute myelocytic leukemia, a rare occurrence. Further research is needed to explore the potential link between Crohn's disease and acute leukemia, particularly with monocytic differentiation.

Area of Science:

  • Gastroenterology
  • Hematology
  • Oncology

Background:

  • Crohn's disease is a chronic inflammatory bowel disease.
  • Leukemia is a cancer of blood-forming tissues.
  • Ulcerative colitis patients may have an increased risk of leukemia.

Observation:

  • Two cases of Crohn's disease patients developing acute myelocytic leukemia within one year at a single hospital.
  • A literature review identified eight previously reported cases, totaling 10 patients with both conditions.
  • Six of the 10 patients had acute myelocytic leukemia, with three exhibiting monocytic differentiation (FAB type M4).

Findings:

  • A notable proportion of patients with Crohn's disease and leukemia presented with acute myelocytic leukemia.
  • Monocytic differentiation (FAB type M4) was observed in three of the 10 reported cases, including the two new cases.
  • The co-occurrence of Crohn's disease and acute myelocytic leukemia, especially with monocytic features, warrants further investigation.

Implications:

  • The findings suggest a potential, though not yet fully understood, association between Crohn's disease and acute myelocytic leukemia.
  • More data is required to confirm and evaluate the risk of developing leukemia in patients with Crohn's disease.
  • This highlights the importance of considering hematological malignancies in patients with inflammatory bowel diseases.

Related Concept Videos